Project Grant HT94252310546
Award Date
9/1/23
Completion Date
8/31/27
Dollars Obligated
$7.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Worcester, MA 01655, USA
Similar Awards
This $7,707,792 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports RNA-based strategies for the prevention and treatment of alphavirus and hemorrhagic fever virus infections. The grant was awarded on September 15, 2024 to the University of Massachusetts Medical School (UMass Medical) in Worcester, MA. As a prominent research institution, UMass Medical has extensive experience securing...
This federal Project Grant award, valued at $153,309.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research by the University of Massachusetts to model the spread of airborne pathogens through lung-on-a-chip technology. The research aims to transform healthcare for military service members and the broader public by developing innovative approaches to disease prevention, diagnosis, and treatment. The...
This $370,151 Cooperative Agreement award was provided by the Uniformed Services University of the Health Sciences under the Uniformed Services University Medical Research Projects program (CFDA 12.750) to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. The funding supports a collaboration between researchers at the Uniformed Services University and the University of Texas Medical Branch to evaluate human-derived nanobodies as potential countermeasures against...
This Project Grant award, totaling $757,212.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Massachusetts Medical School Grants and Contracts Administration Division for the "PRECLINICAL DEVELOPMENT OF AN ORAL NANOBODY PROPHYLACTIC TO PREVENT DIARRHEAL DISEASE." The funding will support research and development of an oral nanobody-based therapeutic to prevent diarrheal disease, with an award...
The University of Massachusetts Amherst was awarded a $557,247 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from February 1, 2023 to January 31, 2026 to develop intracellular bacterial delivery of vaccine antigens to establish T-cell antitumor immunity in triple-negative breast cancer. The Military Medical Research and Development program supports innovative medical research with...
The University of Massachusetts Amherst will receive $570,810 through January 31, 2026 from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to conduct research on intracellular bacterial delivery of vaccine antigens to establish T-cell antitumor immunity in triple-negative breast cancer. The funding will support the university's applied research efforts to transform health care for service members and the public through innovative...
The Defense Health Agency awarded a $456,633 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. The grant funds the development and optimization of a platform for next-generation monoclonal antibodies against Powassan virus and other neuroinvasive tick-borne viruses. Key collaborators include researchers from the United States Army Medical Research Institute of Infectious...
The University of Massachusetts Lowell, through its Office of Research Administration-Lowell, has been awarded a $176,000 Project Grant by the Department of Defense's Military Medical Research and Development program (CFDA 12.420). The grant, effective March 1, 2024 through February 28, 2026, will fund research to transform health care for U.S. military service members and the American public through innovative and impactful biomedical research on topics relevant to military medicine. The...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $5,712,429.00 to the University of Massachusetts Medical School to conduct research on "CRISPR-BASED ADIPOSE THERAPIES FOR ACCELERATED AGING IN IRRADIATED NONHUMAN PRIMATES." The award period runs from July 1, 2025 to June 30, 2028. The research aims to develop novel CRISPR-based therapies to address accelerated aging in...
This Project Grant from the Defense Health Agency provides $734,781 to Formation Venture Engineering Foundry Inc. for precision medicine immunotherapy research under the Military Medical Research and Development program (CFDA 12.420). The research aims to develop medical solutions for treating neurodegeneration in amyotrophic lateral sclerosis patients who test positive for human endogenous retrovirus K. The awardee will conduct applied and advanced biomedical research from June 2023 through...